Literature DB >> 16115179

Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes.

E Dikicioglu1, S Barutca, N Meydan, I Meteoglu.   

Abstract

Diminished oestrogen receptor (ER) expression in the involved axillary lymph nodes (ALN) in breast cancer compared with the primary tumour has been reported in previous studies. We have assessed a wider spectrum of tumour markers (ER, progesterone receptor (PgR), p53, Ki-67 and HER-2/neu) and compared extent and staining intensities at the primary tumour and the involved ALN on specimens of 22 cases with invasive ductal breast cancer. At the involved ALN, both the quantity of positive staining cells and the staining intensities for ER and PgR were decreased (p < 0.001 and p = 0.003, respectively). In contrast, the quantity of positive staining cells (p < 0.004) and the staining intensities for Ki-67 were increased. The differences for HER-2/neu and p53 staining at both sites were insignificant. The immunohistochemical staining properties of both the primary tumour and the ALN metastases showed no correlation with the number of involved ALN (p > 0.05). This study suggested that ALN metastasis might indicate a more unfavourable expression pattern of ER, PgR and Ki-67 in invasive ductal breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115179     DOI: 10.1111/j.1742-1241.2005.00546.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program.

Authors:  Patricia S Steeg
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

2.  Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

Authors:  Anna-Karin Falck; Mårten Fernö; Pär-Ola Bendahl; Lisa Rydén
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 3.  Biological subtypes of breast cancer: Prognostic and therapeutic implications.

Authors:  Ozlem Yersal; Sabri Barutca
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Authors:  Rachel E Ellsworth; Allyson L Toro; Heather L Blackburn; Alisha Decewicz; Brenda Deyarmin; Kimberly A Mamula; Nicholas S Costantino; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Cancer Growth Metastasis       Date:  2015-07-20

5.  Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases.

Authors:  Ibrahim Meteoglu; Ibrahim Halil Erdogdu; Pars Tuncyurek; Adil Coskun; Nil Culhaci; Muhan Erkus; Sabri Barutca
Journal:  Gastroenterol Res Pract       Date:  2015-04-06       Impact factor: 2.260

6.  The correlation between Ki-67 with other prognostic factors in breast cancer: A study in Iranian patients.

Authors:  Seyed-Hamid Madani; Mehrdad Payandeh; Masoud Sadeghi; Hajar Motamed; Edris Sadeghi
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Apr-Jun

7.  Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.

Authors:  Feng-yan Li; San-gang Wu; Juan Zhou; Jia-yuan Sun; Qin Lin; Huan-xin Lin; Xun-xing Guan; Zhen-yu He
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.